Vorma Home Hero

Vor Bio
Medical Affairs

We are dedicated to advancing science to help patients living with autoimmune diseases and support clinical advancements. Our mission drives the work we do every day.

Our Areas of Focus

Myasthenia Gravis (MG)

Mg Hero Image Aspect Ratio 730 468

Sjögren’s 
Disease (SjD)

Sj Hero Image Aspect Ratio 730 468

Upcoming Medical Congress Events

View All Events

Our Latest Publications

Vor Biopharma

2026

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis (UPSTREAM MG)

European Academy of Neurology (EAN 2026)

Geneva, Switzerland
|
2026

A Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis: Trial Design Update

View All Publications

Have a question? Submit a Medical Information Request.

Learn More